期刊文献+

肿瘤靶向的磁性荧光IR780-Fe_3O_4纳米颗粒用于循环肿瘤细胞的检测 被引量:3

Tumor Targeting of Fluorescent Magnetic IR780-Fe_3O_4 Nanoparticles for Detection of Circulating Tumor Cells
下载PDF
导出
摘要 循环肿瘤细胞(Circulating tumor cells,CTCs)的简单、快速分离和检测是目前临床研究中面临的一项挑战。本研究制备了具有肿瘤靶向识别作用的磁性荧光IR780-Fe_3O_4纳米颗粒,并将其用于CTCs的分离和检测。通过电镜、荧光光谱仪和超导量子干涉仪对合成的IR780-Fe_3O_4纳米颗粒进行表征;采用激光共聚焦显微镜和流式细胞仪对IR780-Fe_3O_4纳米颗粒对肿瘤细胞和正常细胞的靶向效果进行了分析;利用激光共聚焦显微镜对IR780-Fe_3O_4纳米颗粒在MCF-7细胞中的位置进行定位;并根据IR780-Fe_3O_4纳米颗粒孵育后肿瘤细胞的荧光强度绘制标准曲线。研究结果表明,IR780-Fe_3O_4能很好地靶向多种CTCs。细胞定位实验进一步表明,IR780-Fe_3O_4主要靶向识别肿瘤细胞的线粒体。通过Fe_3O_4磁性纳米颗粒偶联IR780建立的这种方法可很好地区分肿瘤细胞和正常细胞,并对模拟血液中的CTCs进行了分离和检测。 The tumor targeted fluorescent magnetic IR780-Fe_3O_4 nanoparticles were prepared for separation and detection of circulating tumor cells(CTCs).These IR780-Fe_3O_4 nanoparticles were characterized by electron microscopy,fluorescence spectrometer,and superconducting quantum interferometer.The targeting effect of IR780-Fe_3O_4 nanoparticles was analyzed on the tumor and normal cells by confocal microscope and flow cytometry,and the confocal microscope was used to target the location of IR780-Fe_3O_4 nanoparticles in MCF-7 cells.The standard curve was drawn and evaluated accorded to the IR780-Fe_3O_4 nanoparticles fluorescence intensity of tumor cells after incubation.The results showed that IR780-Fe_3O_4 nanoparticles could target a variety of CTCs.Furthermore,cellular localization experiment proved that IR780-Fe_3O_4 nanoparticles could target the mitochondria of tumor cells.With the method of coupling magnetic Fe_3O_4 nanoparticles,IR780 could well distinguish the tumor and normal cells,which could be used for separating and detecting the CTCs in simulated blood.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2017年第10期1427-1433,共7页 Chinese Journal of Analytical Chemistry
基金 国家自然科学基金(Nos.21375141 81671758) 深圳市专项资金(Nos.JSGG20160331185422390 JCYJ20150403091443298 JCYJ20150521094519473 JCYJ20160429191503002)资助~~
关键词 循环肿瘤细胞 荧光强度 IR780 Fe3O4磁性纳米颗粒 Circulating tumor cells Fluorescence intensity IR780 Fe_3O_4 magnetic nanoparticles
  • 相关文献

参考文献1

二级参考文献79

  • 1Racila E,Euhus D,Weiss A J,et al.Proc Natl Acad Sci USA[J],1998,95(8):4589.
  • 2Harouaka R,Kang Z,Zheng S Y,Cao L.Pharmacol Ther[J],2014,141(2):209.
  • 3Weitz J,Kienle P,Lacroix J,et al.Clin Cancer Res[J],1998,4:343.
  • 4Rosenberg R,Gertler R,Friederichs J,et al.Cytometry[J],2002,49(4):150.
  • 5Muller V,Stahmann N,Riethdorf S,Rau T,Zabel T,Goetz A,Jnicke F,Pantel K.Clin Cancer Res[J],2005,11:3678.
  • 6Vona G,Sabile A,Louha M,et al.Am J Pathol[J],2000,156(1):57.
  • 7Desitter I G B S,Benali-Furet N,Wechsler J,et al.Anticancer Res[J],2011,31(2):427.
  • 8Pinzani P,Salvadori B,Simi L,et al.Hum Pathol[J],2006,37(6):711.
  • 9Hofman V,Bonnetaud C,Ilie M I,et al.Clin Cancer Res[J],2011,17(4):827.
  • 10Khoja L,Backen A,Sloane R,et al.C Br J Cancer[J],2012,106(3):508.

共引文献3

同被引文献30

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部